Nimotuzumab
BT-PK-001
Phase 1 small_molecule active
Quick answer
Nimotuzumab for Solid Tumors is a Phase 1 program (small_molecule) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biotech Pharmaceutical Co.,
- Indication
- Solid Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active